Boston Scientific expands FDA label for Ingevity+ pacing leads
The expanded indication includes conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) for use with pacemakers.
The expanded indication includes conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) for use with pacemakers.
The AI model can accurately predict who is at a high risk of developing sight-threatening diabetic retinopathy up to three years in advance.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Alio starts trial to expand label for remote monitoring device
Firefly and Zeto team up to distribute EEG headset devices
AstraZeneca eyes up transition to eco-friendly inhaler propellant
Apple to add sleep apnoea notification to Series 10 watch